The Plenary of the Consell approved on March 26 a framework agreement for the supply of biosimilar medicines destined for centers dependent on the Department of Universal Health and Public Health, which has a maximum budget of 80.045.624,57 euros for two years.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
